Article: Non-Communicable Diseases and Rare Diseases: A Current and Future Public Health Challenge within Pediatrics

The global burden of non-communicable diseases (NCDs) and rare diseases constitutes a current and future public health challenge within pediatrics [...].

Citing Articles

Assessment of serum biomarker changes following the COVID-19 pandemic and vaccination: a cohort study in Sylhet, Bangladesh.

Akther S, Samiha F, Sony S, Haque M, Hasnat M, Islam S Front Public Health. 2025; 13:1435930.

PMID: 40061468 PMC: 11885237. DOI: 10.3389/fpubh.2025.1435930.

Environmental pediatric physiotherapy and risky play: making the case for a perfect match.

Sturm A, Sandseter E, Scheiber B Front Public Health. 2025; 12:1498794.

PMID: 39911786 PMC: 11794521. DOI: 10.3389/fpubh.2024.1498794.

Multi-omics approaches for understanding gene-environment interactions in noncommunicable diseases: techniques, translation, and equity issues.

Alemu R, Sharew N, Arsano Y, Ahmed M, Tekola-Ayele F, Mersha T Hum Genomics. 2025; 19(1):8.

PMID: 39891174 PMC: 11786457. DOI: 10.1186/s40246-025-00718-9.

The Role of Patient Organizations in Shaping Research, Health Policies, and Health Services for Rare Genetic Diseases: The Dutch Experience.

Poortman Y, Ens-Dokkum M, Nippert I Genes (Basel). 2024; 15(9).

PMID: 39336753 PMC: 11431757. DOI: 10.3390/genes15091162.

Biological Activities and Chemical Profiles of Extracts.

Mejia-Mendez J, Bach H, Lorenzo-Leal A, Navarro-Lopez D, Lopez-Mena E, Hernandez L Plants (Basel). 2023; 12(10).

PMID: 37653861 PMC: 10223013. DOI: 10.3390/plants12101943.

References

1.

Calcaterra V, Zuccotti G . New therapeutic approaches in children's medicine towards solving critical issues in pediatrics. Pharmacol Res. 2022; 183:106394. DOI: 10.1016/j.phrs.2022.106394. View

2.

Case A, Fertig A, Paxson C . The lasting impact of childhood health and circumstance. J Health Econ. 2005; 24(2):365-89. DOI: 10.1016/j.jhealeco.2004.09.008. View

3.

Hadian M, Mozafari M, Mazaheri E, Jabbari A . Challenges of the Health System in Preventing Non-Communicable Diseases; Systematized Review. Int J Prev Med. 2021; 12:71. PMC: 8356955. DOI: 10.4103/ijpvm.IJPVM_487_20. View

4.

Akseer N, Mehta S, Wigle J, Chera R, Brickman Z, Al-Gashm S . Non-communicable diseases among adolescents: current status, determinants, interventions and policies. BMC Public Health. 2020; 20(1):1908. PMC: 7734741. DOI: 10.1186/s12889-020-09988-5. View

5.

Fall C . Fetal programming and the risk of noncommunicable disease. Indian J Pediatr. 2012; 80 Suppl 1:S13-20. PMC: 3793300. DOI: 10.1007/s12098-012-0834-5. View

6.

Reif L, van Olmen J, McNairy M, Ahmed S, Putta N, Bermejo R . Models of lifelong care for children and adolescents with chronic conditions in low-income and middle-income countries: a scoping review. BMJ Glob Health. 2022; 7(7). PMC: 9255401. DOI: 10.1136/bmjgh-2021-007863. View

7.

Budreviciute A, Damiati S, Sabir D, Onder K, Schuller-Goetzburg P, Plakys G . Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors. Front Public Health. 2020; 8:574111. PMC: 7726193. DOI: 10.3389/fpubh.2020.574111. View

8.

Mikkelsen B, Williams J, Rakovac I, Wickramasinghe K, Hennis A, Shin H . Life course approach to prevention and control of non-communicable diseases. BMJ. 2019; 364:l257. PMC: 6349133. DOI: 10.1136/bmj.l257. View

9.

Dain K . Challenges Facing Global Health Networks: The NCD Alliance Experience Comment on "Four Challenges that Global Health Networks Face". Int J Health Policy Manag. 2018; 7(3):282-285. PMC: 5890076. DOI: 10.15171/ijhpm.2017.93. View

10.

Bavisetty S, Grody W, Yazdani S . Emergence of pediatric rare diseases: Review of present policies and opportunities for improvement. Rare Dis. 2014; 1:e23579. PMC: 3932940. DOI: 10.4161/rdis.23579. View

Non-Communicable Diseases and Rare Diseases: A Current and Future Public Health Challenge Within Pediatrics